'Net sales
(including other operating income) of Bayer CropScience has increased 32.07% to
Rs 1,046.40 crore.
Operating
profit margin has jumped from 12.29% to 16.32%, leading to 75.36% rise in
operating profit to Rs 170.80 crore.
Raw
material cost as a % of total sales (net of stock adjustments) increased from
53.97% to 65.99%. Purchase of finished
goods cost fell from 3.20% to 1.50%.
Employee cost decreased from 13.13% to 7.50%. Other expenses fell from 19.66% to
13.50%.
Other
income up 28.82% to Rs 37.1 crore.
PBIDT
rose 64.74% to Rs 207.9 crore. Provision
for interest up 16.33%to Rs 5.7 crore.
Loan funds rose to Rs 105.10 crore as of 31 March 2025 from Rs 47.10
crore as of 31 March 2024. Inventories
r...
Pleaselogin & subscribe to view the full report.
More Reports
-
(13-Jan-2026)
HCL Technologies
Revenue up 13.3% YoY to Rs 33872 crore in Q3FY2026
-
(13-Jan-2026)
Tata Consultancy Services
Revenue up 4.9% YoY to Rs 67087 crore in Q3FY2026
-
(12-Jan-2026)
Krishana Phoschem
Revenue up 116.8% YoY to Rs 659 crore in Q3FY2026
-
(11-Jan-2026)
Avenue Supermarts
Revenue up 13.3% YoY to Rs 18100.9 crore, Net profit up 18.3% yoy to Rs 855.9 crore in Q3FY2026
|
|